MedTrace Logo

Evaluation of Directional Stimulation During the Implantation of Deep Brain Stimulation (DBS) Leads

NCT01764815 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 13

Last updated 2017-07-02

No results posted yet for this study

Summary

The purpose of this study is to provide proof-of-concept that directional stimulation, in an intraoperative setting, is perceivable in a subject and is different from omnidirectional stimulation. The tests will be performed using a dedicated DBS lead connected to external neurostimulator.

Conditions

Interventions

DEVICE

directSTN Acute lead connected to external neurostimulator

Test phase will be performed intra-operatively, prior to chronic lead implant

Sponsors & Collaborators

  • Aleva Neurotherapeutics SA

    lead INDUSTRY

Principal Investigators

  • Claudio Pollo, PD, Dr. med · Inselspital, Bern University Hospital

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-12-31
Primary Completion
2013-11-30
Completion
2013-11-30

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01764815 on ClinicalTrials.gov